Gainers
- HeartBeam, Inc. (NASDAQ:BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) gained 43.5% to $24.20 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo.
- ZW Data Action Technologies Inc. (NASDAQ:CNET) surged 43% to $0.9499. ZW Data Action Technologies reported planned acquisition of Henan Baodun.
- AMTD Digital Inc. (NYSE:HKD) shares jumped 39.9% to $265.00 after jumping 312% on Wednesday.
- Nabriva Therapeutics plc (NASDAQ:NBRV) gained 38% to $0.2650 after the company announced it will effect a 1-for-25 reverse stock split of its outstanding ordinary shares, which will be effective on September 16, 2022.
- Addentax Group Corp. (NASDAQ:ATXG) shares rose 30.2% to $6.22 after jumping 17% on Wednesday.
- STORE Capital Corporation (NYSE:STOR) jumped 20.3% to $32.22 after the company announced it will be acquired by GIC and Oak Street in a $14 billion transaction.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 19.4% to $1.1299.
- Secoo Holding Limited (NASDAQ:SECO) jumped 19.1% to $0.3097 after Aladdin Technology Group agreed to invest RMB1.3 million in the company.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) gained 18% to $1.2036.
- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) gained 16.2% to $0.24.
- Republic First Bancorp, Inc. (NASDAQ:FRBK) jumped 15.8% to $3.00 as the company announced a strategic review; in light of inquiries by multiple parties expressing interest in one or more potential strategic transactions with the company.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares rose 13.9% to $0.2449. Sonnet BioTherapeutics, last month, posted a Q3 loss of $0.13 per share.
- Canoo Inc. (NASDAQ:GOEV) gained 11.7% to $2.9050. Canoo Chairman, CEO Tony Aquila disclosed the purchase of 200k shares of the company’s common stock at an average price of $2.58 per share.
- Enochian Biosciences, Inc. (NASDAQ:ENOB) rose 11.1% to $2.00 after declining around 6% on Wednesday.
- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) jumped 10.5% to $0.84.
- ImmunityBio, Inc. (NASDAQ:IBRX) gained 10% to $7.05.
- EVgo, Inc. (NASDAQ:EVGO) surged 10.1% to $10.23. EVgo launched Connect the Watts National EV Charging Recognition Program.
- Wynn Resorts, Limited (NASDAQ:WYNN) climbed 9.9% to $66.70. Credit Suisse upgraded Wynn Resorts from Neutral to Outperform.
- Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) surged 9.9% to $0.2749.
- China Liberal Education Holdings Limited (NASDAQ:CLEU) gained 9.3% to $0.9710.
- Ra Medical Systems, Inc. (NASDAQ:RMED) rose 8.9% to $0.1742. Ra Medical Systems recently announced a reverse merger agreement with Catheter Precision.
- Humana Inc. (NYSE:HUM) rose 8.2% to $496.26 after the company raised FY22 adjusted EPS guidance above estimates. The company also issued FY25 adjusted EPS guidance of $37 per share.
- Roku, Inc. (NASDAQ:ROKU) jumped 7.7% to $73.58.
- Amyris, Inc. (NASDAQ:AMRS) gained 6% to $4.15.
Losers
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) fell 49.6% to $18.90. Shuttle Pharmaceuticals was awarded new HDAC inhibitor patents for cancer treatment.
- Color Star Technology Co., Ltd. (NASDAQ:CSCW) dropped 44.8% to $0.0651 after the company announced a $5.6 million registered direct offering priced at $0.08 per unit.
- IronNet, Inc. (NASDAQ:IRNT) shares dipped 43.9% to $1.2350 after the company reported worse-than-expected Q2 EPS and sales results. The company also withdrew its FY23 guidance in light of management transitions, restructuring and underperformance of current quarter.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) declined 39.5% to $0.2297 after the company announced the combination of subcutaneous ELX-02 with ivacaftor did not achieve statistical significance for efficacy endpoints in Phase 2 study in Class 1 cystic fibrosis.
- Omeros Corporation (NASDAQ:OMER) fell 28.2% to $3.87 after the company reported Narsoplimab treatment results in critically ill COVID-19 patients in I-SPY COVID trial.
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares fell 24.4% to $0.2685 after gaining around 53% on Wednesday.
- Aditxt, Inc. (NASDAQ:ADTX) fell 22.8% to $8.83. Aditxt announced a 1-for-50 reverse stock split effective on September 14, 2022.
- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shares fell 22% to $ 24.05. Rhythm Pharmaceuticals priced its 4.8 million share public offering of common stock at $26 per share.
- Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 20.1% to $0.3355 after the company reported a proposed public offering of common stock and warrants.
- Adobe Inc. (NASDAQ:ADBE) dropped 17% to $307.25 after the company reported Q3 earnings results, issued Q4 sales guidance below estimates and announced it will acquire Figma for approximately $20 billion in cash and stock.
- Akerna Corp. (NASDAQ:KERN) fell 16.4% to $0.1379.
- SciSparc Ltd. (NASDAQ:SPRC) declined 15.7% to $0.8129. SciSparc announced it entered into an agreement to acquire Wellution for $20 million.
- Arconic Corp (NYSE:ARNC) fell 15.1% to $21.64 as the company lowered its FY22 sales outlook from $9.6 billion-$10 billion to $9.2 billion-$9.5 billion. The company also said it sees Q3 Adjusted EBITDA to be in the range of $135 million to $150 million.
- Wearable Devices Ltd. (NASDAQ:WLDS) fell 14.2% to $ 2.53 on post-IPO volatility after the stock opened for trade on Tuesday.
- The Oncology Institute, Inc. (NASDAQ:TOI) dropped 13.6% to $4.31.
- IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 13.3% to $10.85. IDEAYA priced its 7.62 million share public offering of common stock at $10.50 per share.
- NLS Pharmaceutics AG (NASDAQ:NLSP) dropped 13.3% to $0.90.
- CF Acquisition Corp. VI (NASDAQ:CFVI) fell 13.3% to $12.03.
- RenovoRx, Inc. (NASDAQ:RNXT) declined 12.5% to $2.30.
- First Wave BioPharma, Inc. (NASDAQ:FWBI) fell 12.4% to $2.2126 after dropping 12% on Wednesday.
- Array Technologies, Inc. (NASDAQ:ARRY) declined 11.7% to $17.55. MuddyWatersResearch discussed short report on Zer0es.tv.
- CVR Energy, Inc. (NYSE:CVI) fell 10.6% to $29.27. Wolfe Research downgraded CVR Energy from Outperform to Peer Perform.
- Spectrum Brands Holdings, Inc. (NYSE:SPB) dropped 10.5% to $52.56. Spectrum Brands' will oppose attempt to block the U.S. Department of Justice's Opposition to the sale of its Hardware and Home Improvement division to ASSA ABLOY.
- PBF Energy Inc. (NYSE:PBF) fell 7.7% to $28.09. Shares of oil companies traded lower after rail companies and union negotiators came to a tentative agreement, averting a railroad strike. A strike would have caused supply shortages and lifted oil prices.
